ASPEN AEROGELS INC (ASPN) Forecast, Price Target & Analyst Ratings

NYSE:ASPNUS04523Y1055

Current stock price

3.06 USD
-0.17 (-5.26%)
At close:
3.07 USD
+0.01 (+0.33%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ASPEN AEROGELS INC (ASPN).

Forecast Snapshot

Consensus Price Target

Price Target
$6.63
+ 116.67% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.28
Revenue Estimate
37.399M

ChartMill Buy Consensus

Rating
76.92%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.63
Upside
+ 116.67%
From current price of $3.06 to mean target of $6.63, Based on 13 analyst forecasts
Low
$4.04
Median
$6.63
High
$10.50

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for ASPN. The average price target is 6.63 USD. This implies a price increase of 116.67% is expected in the next year compared to the current price of 3.06.

Analyst Ratings & History

Current Analyst Ratings

ASPN Current Analyst RatingASPN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ASPN Historical Analyst RatingsASPN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
76.92%
ASPN was analyzed by 13 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ASPN.
In the previous month the buy percentage consensus was at a similar level.
ASPN was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05BarclaysMaintains Underweight -> Underweight
2026-02-26TD CowenMaintains Buy -> Buy
2026-02-26Roth CapitalMaintains Buy -> Buy
2025-11-07BarclaysMaintains Underweight -> Underweight
2025-11-07Canaccord GenuityMaintains Buy -> Buy
2025-08-11BarclaysDowngrade Equal-Weight -> Underweight
2025-08-08Canaccord GenuityMaintains Buy -> Buy
2025-05-29BarclaysDowngrade Overweight -> Equal-Weight
2025-02-19B. Riley SecuritiesMaintains Buy -> Buy
2025-02-19BarclaysMaintains Overweight -> Overweight
2025-02-14Roth MKMMaintains Buy -> Buy
2025-02-14Canaccord GenuityMaintains Buy -> Buy
2025-02-14Craig-HallumMaintains Buy -> Buy
2025-02-13Seaport GlobalDowngrade Buy -> Neutral
2025-01-16Canaccord GenuityMaintains Buy -> Buy
2024-11-12BarclaysMaintains Overweight -> Overweight
2024-11-08Roth MKMMaintains Buy -> Buy
2024-10-22Piper SandlerMaintains Overweight -> Overweight
2024-10-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-21Roth MKMReiterate Buy -> Buy
2024-08-20TD CowenMaintains Buy -> Buy
2024-08-09HC Wainwright & Co.Maintains Buy -> Buy
2024-08-08BenchmarkReiterate Buy -> Buy
2024-08-06BarclaysInitiate Overweight
2024-06-14Craig-HallumMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.28
Revenue Estimate
37.399M
Revenue Q2Q
-52.49%
EPS Q2Q
-359.00%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.37%
EPS (1 Month)
0.00%
EPS (3 Months)
-3.26%

Next Earnings Summary

ASPN is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.28 USD and the consensus revenue estimate is 37.40M USD.
The next earnings revenue estimate has been revised downward by 0.37% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ASPN revenue by date.ASPN revenue by date.
238.718M
32.33%
452.699M
89.64%
271.103M
-40.11%
201.75M
-25.58%
280.09M
38.83%
463.08M
65.33%
560.39M
21.01%
675.75M
20.59%
4.291B
535.00%
5.587B
30.20%
EBITDA
YoY % growth
ASPN ebitda by date.ASPN ebitda by date.
-33.885M
51.58%
80.571M
337.78%
N/A
-85.11%
-3.903M
-132.53%
47.615M
1,319.98%
131.58M
176.34%
166.77M
26.74%
194.41M
16.57%
513.73M
164.25%
587.03M
14.27%
EBIT
YoY % growth
ASPN ebit by date.ASPN ebit by date.
-49.203M
37.88%
58.045M
217.97%
-51.392M
-188.54%
-53.026M
-3.18%
3.381M
106.38%
99.96M
2,856.52%
134.54M
34.59%
167.79M
24.71%
750.72M
347.42%
988.38M
31.66%
Operating Margin
ASPN operating margin by date.ASPN operating margin by date.
-20.61%12.82%-18.96%-26.28%1.21%21.59%24.01%24.83%17.50%17.69%
EPS
YoY % growth
ASPN eps by date.ASPN eps by date.
-0.66
70.27%
0.52
178.79%
-0.64
-223.08%
-0.62
3.34%
-0.13
78.24%
0.98
827.27%
2.94
200.00%
3.57
21.53%
4.18
17.14%
4.83
15.61%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28
EPS
Q2Q % growth
-0.28
-359.00%
-0.14
-29.82%
-0.05
31.79%
-0.02
93.59%
-0.04
87.04%
-0.02
85.71%
0.01
118.69%
0.04
263.27%
0.22
714.29%
0.22
1,180.00%
Revenue
Q2Q % growth
37.399M
-52.49%
43.149M
-44.70%
62.096M
-14.96%
67.31M
62.82%
73.885M
97.56%
79.965M
85.32%
83.365M
34.25%
95.424M
41.77%
N/AN/A
EBITDA
Q2Q % growth
-12.136M
-525.23%
-8.038M
-165.20%
7.627M
-49.83%
11.036M
208.32%
13.872M
214.30%
16.677M
307.49%
18.36M
140.72%
23.052M
108.88%
N/AN/A
EBIT
Q2Q % growth
-19.48M
-562.80%
-15.525M
-2,203.72%
-2.522M
-41.68%
759.9K
101.60%
5.049M
125.92%
7.905M
150.92%
9.588M
480.18%
13.719M
1,705.37%
N/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ASPN Yearly Revenue VS EstimatesASPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
ASPN Yearly EPS VS EstimatesASPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
52.26%
EPS Next 5 Year
49.94%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
21.77%
Revenue Next 5 Year
19.26%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
33.78%
EBIT Next 5 Year
20.89%

ASPEN AEROGELS INC / ASPN Forecast FAQ

What do analysts expect the price target to be for ASPEN AEROGELS INC (ASPN)?

13 analysts have analysed ASPN and the average price target is 6.63 USD. This implies a price increase of 116.67% is expected in the next year compared to the current price of 3.06.

Can you provide the upcoming earnings date for ASPEN AEROGELS INC?

ASPEN AEROGELS INC (ASPN) will report earnings on 2026-05-06.

What are the consensus estimates for ASPEN AEROGELS INC (ASPN) next earnings?

The consensus EPS estimate for the next earnings of ASPEN AEROGELS INC (ASPN) is -0.28 USD and the consensus revenue estimate is 37.40M USD.

What is the expected long term growth rate for ASPEN AEROGELS INC (ASPN)?

The expected long term growth rate for ASPEN AEROGELS INC (ASPN) is 21.77%.